Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Monday, 5 February 2018

Novo Nordisk A/S purchases B shares worth DKK 954 million from Novo Holdings A/S under the 2018 share repurchase programme

Novo Nordisk A/S    

Published: 20:30 CET 05-02-2018 /GlobeNewswire /Source: Novo Nordisk A/S / : NOVO B /ISIN: DK0060534915

Novo Nordisk A/S purchases B shares worth DKK 954 million from Novo Holdings A/S under the 2018 share repurchase programme

Bagsværd, Denmark, 5 February 2018 - Novo Nordisk A/S has today entered into an agreement to purchase 3,087,410 B shares (nominal DKK 0.20) of a value of DKK 954 million from Novo Holdings A/S. This transaction is part of Novo Nordisk's 2018 share repurchase programme of up to a total of DKK 14.0 billion to be executed during a 12 months period beginning 1 February 2018. The transaction price is DKK 308.90 per share and has been calculated as the volume weighted average market price from 1 February to 5 February 2018 in the open window following the announcement of Novo Nordisk A/S' 2017 financial results.

Prior to the sale of B shares, Novo Holdings A/S' ownership of Novo Nordisk A/S was 28.1% of the share capital and 75.5% of the votes. Following the transaction, Novo Holdings A/S owns 107,487,200 A shares (nominal DKK 0.20) and 32,145,318 B shares (nominal DKK 0.20), corresponding to 27.9% of the capital and 75.4% of the votes in Novo Nordisk A/S.


The transaction is in line with the announcement on 1 February 2018 that Novo Holdings A/S intends to maintain its ownership of Novo Nordisk A/S share capital around 28%.


Transactions related to Novo Nordisk's incentive programmes have resulted in a net transfer from Novo Nordisk of 495,918 B shares in the period from 1 February 2018 to 5 February 2018. Novo Nordisk A/S owns a total of 63,102,269 B shares of DKK 0.20, corresponding to 2.5% of the share capital, as treasury shares including this transaction. The total amount of A and B shares in the company is 2,500,000,000 including treasury shares.


Further information

Novo Holdings Communication



Christian Mostrup Scheel

+45 3067 4805





Novo Nordisk Media:



Katrine Sperling

+45 3079 6718


Ken Inchausti (US)

+1 609 786 8316





Novo Nordisk Investors:



Peter Hugreffe Ankersen

+45 3075 9085


Hanna Ögren

+45 3079 8519


Anders Mikkelsen

+45 3079 4461


Christina Kjær

+45 3079 3009


Kasper Veje (US)

+1 609 235 8567



Company announcement No 9 / 2017 



This announcement is distributed by Nasdaq Corporate Solutions (One Liberty Plaza, 165 Broadway, New York, NY 10006. Tel: +1 212 401 8700. www.nasdaqomx.com) on behalf of Nasdaq Corporate Solutions clients. Source: Novo Nordisk A/S, Novo Allé, Bagsvaerd DK-2880, Denmark
If you would like to unsubscribe and stop receiving these e-mails click here.